In this issue:
Risk of natalizumab-associated PML in patients with MS
Retinal ganglion cell loss is associated with new lesions in the optic radiations
Comorbidity in MS is associated with diagnostic delays and increased mortality
25[OH]D deficiency and risk of MS among women in the Finnish maternity cohort
Reversibility of the effects of natalizumab on peripheral immune cell dynamics
Dietary sodium intake and the risk of MS
EBV, CMV, and MS susceptibility
Concussion in adolescence and MS risk
Efficacy of modafinil in the treatment of MS fatigue
Multiple biomarkers improve the prediction of MS in CIS
Please login below to download this issue (PDF)